Q3 2025 confirmed what many venture observers suspected: startups deploying or developing AI technologies continue to command higher valuations than their non-AI peers, with 2.5x higher revenue multiples (20x vs. 8x). ...more
12/12/2025
/ Artificial Intelligence ,
Business Valuations ,
Healthcare ,
Innovation ,
Investment ,
Investors ,
Machine Learning ,
Startups ,
Sustainability ,
Technology Sector ,
Valuation
In Q3 2025, venture capital activity revealed a telling split in the fundraising landscape. Series A and B rounds saw improvements in both capital raised valuations ranging from 1.6% to 29%, marking investor confidence in...more
Early-stage strength, late-stage strain, and an enduring AI premium define this quarter’s venture landscape....more
11/12/2025
/ Artificial Intelligence ,
Capital Markets ,
Capital Raising ,
Emerging Technologies ,
Entrepreneurs ,
Equity Financing ,
Investment ,
Investors ,
Machine Learning ,
Startups ,
Technology Sector ,
Venture Capital
Founder preferred stock is on the rise, featured in nearly 11% of companies that closed priced equity rounds in H1, up from 6% in 2023. These provisions often support tax-efficient founder liquidity structuring and may signal...more
10/8/2025
/ Capital Raising ,
Contract Terms ,
Convertible Debt ,
Convertible Notes ,
Early Stage Companies ,
Entrepreneurs ,
Equity Financing ,
Exit Strategies ,
Investors ,
Liquidity ,
Seed Financing ,
Startups ,
Strategic Planning ,
Tax Planning ,
Venture Capital
Artificial Intelligence companies continued to post strong valuation premiums at Series A, particularly in sectors like Industrials, Healthcare, Financials, and Tech. ...more
Seed through Series C deal activity gained ground in Q2 2025, with deal sizes up between 5.5% and 22% and valuations rising by as much as 60% compared to Q1. While this reflects improving confidence in early-stage ventures,...more
If you’re raising early-stage capital, the outlook appears strong, but for late-stage companies, the bar is higher than ever. In partnership with Aumni, a J.P. Morgan company, we’re pleased to share the Q2 2025 edition of the...more
Fundraising dynamics continued to evolve in Q1 2025, with early-stage companies seeing a modest uptick in down rounds while late-stage companies experienced fewer. Down rounds rose to 20.8% of deals at the Seed through Series...more
Convertible instruments held steady in Q1 2025, but the terms are shifting in favor of investors. Interest rates on convertible notes rose by 200 to 300 basis points, and discount rates climbed as high as 10.5 percentage...more
7/24/2025
/ Contract Terms ,
Convertible Notes ,
Financing ,
Interest Rates ,
Investment ,
Private Equity ,
Small Business ,
Startups ,
Valuation ,
Venture Capital ,
Venture Funding
AI continues to be the standout in venture dealmaking, with Q1 2025 extending the sector’s winning streak. AI companies raised more capital and achieved significantly higher pre-money valuations than their non-AI...more
After a cautiously optimistic close to 2024, Q1 2025 brought a measured pullback in venture activity. Rather than a dramatic downturn, the market saw a strategic recalibration....more
In this edition of the J.P. Morgan Venture Beacon, we analyze venture deals from Series Seed through Series D+ to surface the real-time dynamics shaping today’s startup ecosystem. Produced in collaboration with J.P. Morgan |...more
Your nascent startup may be poised to change the world—but do investors see it that way? When you’re in the earliest stages, it can be tough to distinguish yourself among a field of founders all vying for investors’ limited...more
You’ve conceived the next great innovation, but actually pushing it out into the world is a whole other endeavor—and it's not cheap.
For New York Tech Week, Fenwick corporate partner Al Cooper sat down with some of...more